Cargando…

Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients

Facioscapulohumeral dystrophy type1 (FSHD1) patients with a shortened D4Z4 repeat containing the DUX4 gene have a broad spectrum of clinical manifestations. In addition, high expression of DUX4 protein with an aberrant C terminus is frequently identified in B cell acute lymphoblastic leukemia. We in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurashige, Takashi, Morino, Hiroyuki, Ueno, Hiroki, Murao, Tomomi, Watanabe, Tomoaki, Hinoi, Takao, Nishino, Ichizo, Torii, Tsuyoshi, Maruyama, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873551/
https://www.ncbi.nlm.nih.gov/pubmed/36336708
http://dx.doi.org/10.1038/s10038-022-01095-0
_version_ 1784877622157639680
author Kurashige, Takashi
Morino, Hiroyuki
Ueno, Hiroki
Murao, Tomomi
Watanabe, Tomoaki
Hinoi, Takao
Nishino, Ichizo
Torii, Tsuyoshi
Maruyama, Hirofumi
author_facet Kurashige, Takashi
Morino, Hiroyuki
Ueno, Hiroki
Murao, Tomomi
Watanabe, Tomoaki
Hinoi, Takao
Nishino, Ichizo
Torii, Tsuyoshi
Maruyama, Hirofumi
author_sort Kurashige, Takashi
collection PubMed
description Facioscapulohumeral dystrophy type1 (FSHD1) patients with a shortened D4Z4 repeat containing the DUX4 gene have a broad spectrum of clinical manifestations. In addition, high expression of DUX4 protein with an aberrant C terminus is frequently identified in B cell acute lymphoblastic leukemia. We investigated clinical manifestations in 31 FSHD1 patients and 30 non-affected individuals. Gastrointestinal cancers (gastric and colorectal cancers) increased after the age of 40 years and were more frequently observed in FSHD1 patients (n = 10) than in non-affected individuals (n = 2, p = 0.0217), though the incidence of cancers occurring in non-gastrointestinal tissues of FSHD1 patients was the same as that of non-affected individuals (p > 0.999). These comorbidities of FSHD1 patients were not associated with D4Z4 repeat number. Our results suggest that gastrointestinal cancers are among the extramuscular manifestations of adult FSHD1 patients, and do not depend on D4Z4 repeat number.
format Online
Article
Text
id pubmed-9873551
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-98735512023-01-26 Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients Kurashige, Takashi Morino, Hiroyuki Ueno, Hiroki Murao, Tomomi Watanabe, Tomoaki Hinoi, Takao Nishino, Ichizo Torii, Tsuyoshi Maruyama, Hirofumi J Hum Genet Brief Communication Facioscapulohumeral dystrophy type1 (FSHD1) patients with a shortened D4Z4 repeat containing the DUX4 gene have a broad spectrum of clinical manifestations. In addition, high expression of DUX4 protein with an aberrant C terminus is frequently identified in B cell acute lymphoblastic leukemia. We investigated clinical manifestations in 31 FSHD1 patients and 30 non-affected individuals. Gastrointestinal cancers (gastric and colorectal cancers) increased after the age of 40 years and were more frequently observed in FSHD1 patients (n = 10) than in non-affected individuals (n = 2, p = 0.0217), though the incidence of cancers occurring in non-gastrointestinal tissues of FSHD1 patients was the same as that of non-affected individuals (p > 0.999). These comorbidities of FSHD1 patients were not associated with D4Z4 repeat number. Our results suggest that gastrointestinal cancers are among the extramuscular manifestations of adult FSHD1 patients, and do not depend on D4Z4 repeat number. Springer Nature Singapore 2022-11-07 2023 /pmc/articles/PMC9873551/ /pubmed/36336708 http://dx.doi.org/10.1038/s10038-022-01095-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Brief Communication
Kurashige, Takashi
Morino, Hiroyuki
Ueno, Hiroki
Murao, Tomomi
Watanabe, Tomoaki
Hinoi, Takao
Nishino, Ichizo
Torii, Tsuyoshi
Maruyama, Hirofumi
Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients
title Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients
title_full Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients
title_fullStr Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients
title_full_unstemmed Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients
title_short Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients
title_sort gastrointestinal cancer occurs as extramuscular manifestation in fshd1 patients
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873551/
https://www.ncbi.nlm.nih.gov/pubmed/36336708
http://dx.doi.org/10.1038/s10038-022-01095-0
work_keys_str_mv AT kurashigetakashi gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients
AT morinohiroyuki gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients
AT uenohiroki gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients
AT muraotomomi gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients
AT watanabetomoaki gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients
AT hinoitakao gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients
AT nishinoichizo gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients
AT toriitsuyoshi gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients
AT maruyamahirofumi gastrointestinalcanceroccursasextramuscularmanifestationinfshd1patients